| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |